GT Biopharma (GTBP) had the highest return between December 1, 2010 and December 31, 2012 by a US stock, returning 534,157,526.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 12/1/2010 - 12/31/2012 | 534,157,526.32% |
QXO (QXO) | 12/1/2010 - 12/31/2012 | 4,032,075% |
Sequans Communications (SQNS) | 12/1/2010 - 12/31/2012 | 2,819,177.11% |
Castellum (CTM) | 12/1/2010 - 12/31/2012 | 815,117.39% |
Intellinetics (INLX) | 12/1/2010 - 12/31/2012 | 8,066.67% |
Par Pacific (PARR) | 12/1/2010 - 12/31/2012 | 1,900% |
Xpel (XPEL) | 12/1/2010 - 12/31/2012 | 1,754.84% |
Nova Lifestyle I (NVFY) | 12/1/2010 - 12/31/2012 | 1,266.67% |
Actinium Pharmaceuticals (ATNM) | 12/1/2010 - 12/31/2012 | 1,263.64% |
Kazia Therapeutics Ltd ADR (KZIA) | 12/1/2010 - 12/31/2012 | 1,236.33% |
Natural Health Trend (NHTC) | 12/1/2010 - 12/31/2012 | 1,011.36% |
Patrick Industries (PATK) | 12/1/2010 - 12/31/2012 | 789.19% |
Heritage Global (HGBL) | 12/1/2010 - 12/31/2012 | 746.15% |
Intelligent Protection Management (IPM) | 12/1/2010 - 12/31/2012 | 681.25% |
Barfresh Food (BRFH) | 12/1/2010 - 12/31/2012 | 670% |
Where Food Comes From (WFCF) | 12/1/2010 - 12/31/2012 | 650.01% |
Aemetis (AMTX) | 12/1/2010 - 12/31/2012 | 600% |
Netcapital (NCPL) | 12/1/2010 - 12/31/2012 | 600% |
ACADIA Pharmaceuticals (ACAD) | 12/1/2010 - 12/31/2012 | 554.93% |
Usio (USIO) | 12/1/2010 - 12/31/2012 | 550% |
Consumer Portfolio Services (CPSS) | 12/1/2010 - 12/31/2012 | 516.09% |
Mawson Infrastructure (MIGI) | 12/1/2010 - 12/31/2012 | 500% |
Regeneron Pharmaceuticals (REGN) | 12/1/2010 - 12/31/2012 | 487.47% |
Expedia (EXPE) | 12/1/2010 - 12/31/2012 | 467% |
Precision Optics Corporation, Inc Common stock (POCI) | 12/1/2010 - 12/31/2012 | 466.67% |
